Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice.
Patients infected with Helicobacter pylori mount an immune response which fails to clear the infection and may contribute to disease. Mice can be protected by immunization. To further characterize the H. pylori-mouse model, stomachs of unimmunized or intranasally immunized C57BL/6 mice were quantitatively cultured 3 days and 1, 2, 4, 8, 16, 32, and 52 weeks after challenge with H. pylori. At 3 days and 1 week after challenge, colonization was the same in the immunized and unimmunized mice. By 2 weeks after challenge, the immunized mice had a >2-log decrease in bacterial load, and at all later time points, they either were culture negative or had at least a 2-log decrease in bacterial load. Gastritis in the immunized mice peaked at 1 to 2 weeks after challenge and was characterized by a mixed inflammatory infiltrate and epithelial proliferation centered at the transition between corpus and antrum. By 52 weeks postchallenge, the gastric histology in the immunized mice was not different from that in control unchallenged mice. The unimmunized group began to show a reduction in bacterial load as early as 16 weeks after challenge, and by 52 weeks seven of eight unimmunized mice had developed gastritis and reduced bacterial loads. These results indicate that prophylactic immunization does not prevent colonization by H. pylori but enables mice to clear the infection or significantly reduce the number of colonizing bacteria. The reduction in bacterial load is associated with gastric inflammation that subsides over time.
Garhart
Christine A
CA
Departments of Pathology. Pediatrics, Case Western Reserve University, Cleveland, Ohio 44106.
Redline
Raymond W
RW
Nedrud
John G
JG
Czinn
Steven J
SJ
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D005260:Female; D005756:Gastritis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control; D016481:Helicobacter Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control; D016480:Helicobacter pylori / Q000254:growth & development* / Q000276:immunology; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D013270:Stomach / Q000473:pathology; D014611:Vaccination
D000907:Antibodies, Bacterial